Poly-epsilon-caprolactone/hydroxyapatite composites for bone regeneration: in vitro characterization and human osteoblast response.
about
Calcium Orthophosphate-Containing Biocomposites and Hybrid Biomaterials for Biomedical ApplicationsA comparative study on in vitro osteogenic priming potential of electron spun scaffold PLLA/HA/Col, PLLA/HA, and PLLA/Col for tissue engineering applicationBiocomposites and hybrid biomaterials based on calcium orthophosphatesComputed tomography-based tissue-engineered scaffolds in craniomaxillofacial surgery.Is macroporosity absolutely required for preliminary in vitro bone biomaterial study? A comparison between porous materials and flat materials.Does translational symmetry matter on the micro scale? Fibroblastic and osteoblastic interactions with the topographically distinct poly(ε-caprolactone)/hydroxyapatite thin filmsSelective laser sintering fabrication of nano-hydroxyapatite/poly-ε-caprolactone scaffolds for bone tissue engineering applications.Osteogenic differentiation of human mesenchymal stem cells in freeze-gelled chitosan/nano β-tricalcium phosphate porous scaffolds crosslinked with genipin.Improvement of Distribution and Osteogenic Differentiation of Human Mesenchymal Stem Cells by Hyaluronic Acid and β-Tricalcium Phosphate-Coated Polymeric Scaffold In Vitro.Development of an indirect stereolithography technology for scaffold fabrication with a wide range of biomaterial selectivity.Physical properties and cellular responses to crosslinkable poly(propylene fumarate)/hydroxyapatite nanocomposites.Temperature-driven processing techniques for manufacturing fully interconnected porous scaffolds in bone tissue engineering.Adult multipotent stromal cell technology for bone regeneration: a review.Polymer-ceramic spiral structured scaffolds for bone tissue engineering: effect of hydroxyapatite composition on human fetal osteoblasts.Potassium citrate prevents increased osteoclastogenesis resulting from acidic conditions: Implication for the treatment of postmenopausal bone loss.Bacterial inhibition potential of 3D rapid-prototyped magnesium-based porous composite scaffolds--an in vitro efficacy study.Poly(ε-caprolactone) scaffolds of highly controlled porosity and interconnectivity derived from co-continuous polymer blends: model bead and cell infiltration behavior.A polycaprolactone/cuttlefish bone-derived hydroxyapatite composite porous scaffold for bone tissue engineering.Hydroxyapatite scaffolds infiltrated with thermally crosslinked polycaprolactone fumarate and polycaprolactone itaconate.Preparation, characterization and in vitro testing of poly(lactic-co-glycolic) acid/barium titanate nanoparticle composites for enhanced cellular proliferation.Biological and mechanical properties of novel composites based on supramolecular polycaprolactone and functionalized hydroxyapatite.Conditioned media enhance osteogenic differentiation on poly(L-lactide-co-epsilon-caprolactone)/hydroxyapatite scaffolds and chondrogenic differentiation in alginate.Surface controlled biomimetic coating of polycaprolactone nanofiber meshes to be used as bone extracellular matrix analogues.Biomedical nanocomposites of hydroxyapatite/polycaprolactone obtained by surfactant mediation.The roles of matrix polymer crystallinity and hydroxyapatite nanoparticles in modulating material properties of photo-crosslinked composites and bone marrow stromal cell responsesPreparation of laminated poly(ε-caprolactone)-gelatin-hydroxyapatite nanocomposite scaffold bioengineered via compound techniques for bone substitution.Direct scaffolding of biomimetic hydroxyapatite-gelatin nanocomposites using aminosilane cross-linker for bone regeneration.Response of rat osteoblasts to polycaprolactone/chitosan blend porous scaffolds.A unique three-dimensional SCID-polymeric scaffold (SCID-synth-hu) model for in vivo expansion of human primary multiple myeloma cells.Bone augmentation using a highly porous PLGA/β-TCP scaffold containing fibroblast growth factor-2.Porous scaffolds of polycaprolactone reinforced with in situ generated hydroxyapatite for bone tissue engineering.Osteogenic scaffolds for bone reconstruction.A composite material model for improved bone formation.Engineering calcium deposits on polycaprolactone scaffolds for intravascular applications using primary human osteoblasts.Mimicking nanofibrous hybrid bone substitute for mesenchymal stem cells differentiation into osteogenesis.Optimization of poly(ε-caprolactone) surface properties for apatite formation and improved osteogenic stimulation.Enhanced adhesion of preosteoblasts inside 3D PCL scaffolds by polydopamine coating and mineralization.The pore size of polycaprolactone scaffolds has limited influence on bone regeneration in an in vivo model.Nanobioengineered electrospun composite nanofibers and osteoblasts for bone regeneration.Electrospun-modified nanofibrous scaffolds for the mineralization of osteoblast cells.
P2860
Q26799302-DD42C3EA-D660-4223-A3F9-D06969F6EFD7Q28542409-2D6FFEDE-4784-4E2D-B87C-D82D3CFE5245Q28709942-3F7C86FA-C14A-4582-A657-0A6856A5AB83Q33290871-E6CACAB4-A804-4B1D-94BA-EB4DDB863554Q33649702-95EBCA9B-E9C3-4002-8198-9665AC51B243Q34050315-2C0DD8EB-BFEF-4D97-B019-603B6D003126Q35034039-71B9AB1D-0438-42FE-884B-2401178E9E36Q35689778-7EF2CADB-3731-498B-9BF1-8D8CF708283AQ35815676-0C9930FD-76A0-401E-B4B0-459DE80E9B5AQ36189040-2EABD2CB-C7F0-45D5-86BF-7EC67FFF4276Q36725900-A8E4D36A-9F49-4F93-B087-B11F6F020683Q37834558-500ABABE-45E7-4165-AFDB-6175A8A0DC39Q38065221-80ABC66B-077A-431E-B598-2C0D56C885A1Q38309364-4E6F13C0-680D-4CE5-B166-E327918C318AQ38675617-60CF8AF1-3A24-4DCD-9DA4-D6D13AC94D7DQ38837208-55D15DED-F6CE-4845-AC82-7583AA5BA92CQ38981472-2038F1CE-A279-456B-BED9-0283543693D2Q39060188-A8D648E4-E128-4816-8D3F-F5CA9825A390Q39533264-FBF5123F-29C5-4080-A626-C4E439BCCC20Q39638947-FBE62BA7-7591-44BB-B674-97F7EE3D5A5CQ39688736-1DD3DBFB-F8ED-4360-AD90-F8905F591C72Q39695328-08F42158-D617-424F-BE2F-D584B4B30948Q39929556-00A97CE6-BA71-460E-9E3D-19506C1431BCQ40153372-96A404EC-8A5A-4EE5-B258-236658BA1647Q40506886-8E72268D-BE11-4EFB-9013-C379F5C36340Q42174855-1C46D931-DB88-4B9F-A521-D381A7B41866Q42364392-6BF0A6F3-FA7B-4ED1-8B79-6B789D5D1541Q42610429-9EBD0F1C-F4B3-4999-8FB8-4E4151D26A08Q42728666-F298A98B-6E46-48C4-83C7-6EE01FCC7CE2Q42800647-45680C67-F4DE-49F7-BFDC-3C4438D6830EQ42835064-DA6D09A8-5992-4F8E-B854-85F179314D2CQ43079098-6E50583F-0956-4000-9FBC-3A4C5879BA11Q43137598-ED25DB08-08E7-4FAB-A687-64EA0ECD0B9CQ44058262-4EEF486C-E369-4D43-89F1-C5A3345C7BDBQ44474330-475990EF-4056-4563-B5CF-C91DF316CAF7Q45793205-FC2CE482-CA85-48D3-ABB1-0A1156005BA8Q46059548-5B03B47A-F801-47AB-B4B7-29BF81728E16Q46135473-306A3A21-5178-4E89-8DC1-790A56D1096AQ46277499-E938255C-C0A0-4D8D-BDE5-118A87DEE4A0Q46279365-2B366885-CE3C-41EB-9E4A-58EC5E1DEA0C
P2860
Poly-epsilon-caprolactone/hydroxyapatite composites for bone regeneration: in vitro characterization and human osteoblast response.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Poly-epsilon-caprolactone/hydr ...... and human osteoblast response.
@en
type
label
Poly-epsilon-caprolactone/hydr ...... and human osteoblast response.
@en
prefLabel
Poly-epsilon-caprolactone/hydr ...... and human osteoblast response.
@en
P2093
P356
P1476
Poly-epsilon-caprolactone/hydr ...... and human osteoblast response.
@en
P2093
Ambrosio L
Ciapetti G
P2860
P304
P356
10.1002/JBM.A.30528
P577
2006-01-01T00:00:00Z